Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors

被引:0
作者
Kayondo, Jonathan K. [1 ]
Ndembi, Nicaise [2 ]
Parry, Chris M. [2 ]
Cane, Patricia A. [3 ]
Hue, Stephane [4 ]
Goodall, Ruth [5 ]
Dunn, David T. [5 ]
Kaleebu, Pontiano [1 ,2 ]
Pillay, Deenan [4 ]
Mbisa, Jean L. [3 ]
机构
[1] Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda
[2] UVRI, MRC, Uganda Res Unit AIDS, Entebbe, Uganda
[3] Publ Hlth England, Virus Reference Dept, London, England
[4] UCL, Dept Infect & Immun, London, England
[5] UCL, MRC, Clin Trials Unit, London, England
基金
英国惠康基金;
关键词
DRUG-RESISTANCE; HIV; INTERRUPTION; INFECTION;
D O I
10.1089/aid.2015.0035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 50 条
  • [31] Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs
    Staudinger, R
    Abraham, NG
    Levere, RD
    Kappas, A
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1996, 108 (01) : 47 - 54
  • [32] Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors
    Domaoal, RA
    Demeter, LM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (09) : 1735 - 1751
  • [33] In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients
    Gianotti, N
    Galli, L
    Boeri, E
    Maillard, M
    Serra, G
    Ratti, D
    Gallotta, G
    Vacchini, D
    Tremolada, Y
    Lazzarin, A
    Clementi, M
    Castagna, A
    NEW MICROBIOLOGICA, 2005, 28 (04) : 319 - 326
  • [34] Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review
    Nurjannah
    Jayanti, Sri
    Tanoerahardjo, Francisca Srioetami
    Al Musyahadah, Ummu Syauqah
    Sukowati, Caecilia Hapsari Ceriapuri
    Massi, Muhammad Nasrum
    CURRENT HIV/AIDS REPORTS, 2024, 21 (02) : 31 - 39
  • [35] Mutational studies of human immunodeficiency virus type 1 reverse transcriptase: The involvement of residues 183 and 184 in the fidelity of DNA synthesis
    Bakhanashvili, M
    Avidan, O
    Hizi, A
    FEBS LETTERS, 1996, 391 (03) : 257 - 262
  • [36] Early treatment with reverse transcriptase inhibitors significantly suppresses peak plasma IFNα in vivo during acute simian immunodeficiency virus infection
    George, Jeffy
    Renn, Lynnsey
    Verthelyi, Daniela
    Roederer, Mario
    Rabin, Ronald L.
    Mattapallil, Joseph J.
    CELLULAR IMMUNOLOGY, 2016, 310 : 156 - 164
  • [37] Mutations in the human immunodeficiency virus type 1 reverse transcriptase gene observed in stavudine and didanosine strains obtained by in vitro passages
    Bossi, P
    Yvon, A
    Mouroux, M
    Huraux, JM
    Agut, H
    Calvez, V
    RESEARCH IN VIROLOGY, 1998, 149 (06): : 355 - 361
  • [38] Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures
    Robinson, Barry
    Li, Zhenzhong
    Nath, Avindra
    JOURNAL OF NEUROVIROLOGY, 2007, 13 (02) : 160 - 167
  • [39] Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures
    Barry Robinson
    Zhenzhong Li
    Avindra Nath
    Journal of NeuroVirology, 2007, 13 : 160 - 167
  • [40] Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay
    Awad, RJK
    Corrigan, GE
    Ekstrand, DHL
    Thorstensson, R
    Kallander, CFR
    Gronowitz, JS
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) : 1080 - 1089